---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "G7zYI16+YDEhEO/bsUg8eJPSHkOypXRZSNkP7BczfZFjGJyMQWslii7f0h8Mbf1YzkFO0tDLuq8KRYlcSoAnb503jy17Vp0/SnIWB1SQ9XrCBhy0z8Se69C5W3T4rnH5DTPpgBapDoeQlKCGcaP6vF+ICTX4GW7sUPIfLCa86jW9MeHTT4VOc74p90NwJCXUCTmyg6oyetzi4BsD05CNj2vZWkBWArzgrP5HFg88fYYynOZOypX+go9iwM4IUBtWjIC51Wi/Fqd7lvUqylL8jYJSLz9jqte8bIeQHJVrfq0LrqjhqyTO3TAYbLz/T5130EBmZASJmvpCZrsLbybR9mygWCD2dPpJ2bRlx7jXPG8=;DAZI5xwCDjyE9Q5vRtJDTQ=="
---

